Delivery Order SPE2DB25D3022-SPE2DB25FWAPF

Award Date 2/11/25
Potential Completion Date 3/5/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is valued at $12,604.63 and has an ultimate completion date of February 4, 2025. The contract covers the provision of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999,...
This is a $12,236.27 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The order is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product, and has a completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $23,655.02, is for the delivery of the pharmaceutical product SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty pharmaceutical product. The contract has a firm fixed price and a ceiling value of $11,827.51. It has an ultimate completion date of August 5, 2024. This delivery order contract is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract has a ceiling value of $12,236.27 and a period of performance through December 30, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract is a firm-fixed price delivery order with a ceiling value of $47,103.62 and a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $11,827.51, is for the provision of SKYRIZI 360 MG/2.4 ML on-body 2.4ML to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor and the award does not include any set-aside designations....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,827.51, is for the delivery of the pharmaceutical product SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The contract is a firm fixed-price delivery order with a completion date of December 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The $23,655.02 firm-fixed-price contract has a completion date of November 14, 2024. The award is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML medical products. The $12,604.63 firm-fixed-price delivery order has a completion date of February 12, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare...
  • SPE2DB25D3022
    Indefinite Delivery Contract
  • SPE2DB25D3022-SPE2DB25FWAPF
    Delivery Order

This is a delivery order award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The delivery order is priced at a firm fixed price of $12,604.63 and has a completion date of March 5, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated as a set-aside contract.

Generated 5/13/25, 10:03 AM